| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -5.2e-05 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -1.2e-05 | 1 |